- NSE
- TORNTPHARM
- BSE
- 500420
- ISIN
- INE685A01028
TORRENT PHARMACEUTICALS L
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹4,780.00
+₹30.00 (+0.63%)
NSE close ·
TORRENT PHARMACEUTICALS L closed at ₹4,780.00 on 9 Nov 2026, up 0.63% on the day, and is up 33.52% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹3,686.50 to ₹5,122.80.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,81,816 Cr
- P/E (TTM)
- 80.7
- Industry P/E
- 35.5
- EPS (TTM)
- ₹59.20
- P/B
- 9.90
- Book value
- ₹483.03
- ROE
- 11.6%
- ROCE
- 11.5%
- Debt/equity
- 0.76
- Operating margin
- 21.6%
- Net margin
- 12.2%
- Dividend yield
- 0.80%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +42.21% | +19.01% |
| Net profit | −1.92% | +16.31% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹4,969 Cr | ₹534 Cr | −9.64% | ₹14.05 |
| Jun 2026 | ₹4,909 Cr | ₹566 Cr | +3.28% | ₹14.87 |
| Mar 2026 | ₹4,180 Cr | ₹364 Cr | −26.91% | ₹11.51 |
| Dec 2025 | ₹3,290 Cr | ₹635 Cr | +26.24% | ₹18.77 |
| Sep 2025 | ₹3,275 Cr | ₹591 Cr | +30.46% | ₹17.45 |
| Jun 2025 | ₹3,141 Cr | ₹548 Cr | +19.91% | ₹16.19 |
| Mar 2025 | ₹2,941 Cr | ₹498 Cr | +10.91% | ₹14.71 |
| Dec 2024 | ₹2,842 Cr | ₹503 Cr | +13.54% | ₹14.88 |
Armor risk check
TORRENT PHARMACEUTICALS L moves about 1.4× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is TORRENT PHARMACEUTICALS L's share price today?
TORRENT PHARMACEUTICALS L (NSE: TORNTPHARM) closed at ₹4,780.00 on 9 Nov 2026, up 0.63% from the previous close of ₹4,750.00. It traded between ₹4,734.50 and ₹4,835.00 that day.
What are TORRENT PHARMACEUTICALS L's 52-week high and low?
Over the last 52 weeks TORRENT PHARMACEUTICALS L traded between ₹3,602.00 and ₹5,250.00, adjusted for splits and bonuses.
What are TORRENT PHARMACEUTICALS L's NSE symbol, BSE code and ISIN?
TORRENT PHARMACEUTICALS L has NSE symbol TORNTPHARM, BSE code 500420, ISIN INE685A01028.
How has TORRENT PHARMACEUTICALS L performed over 1, 3 and 5 years?
TORRENT PHARMACEUTICALS L's share price return: 1Y +33.52%, 3Y +32.58% a year, 5Y +27.41% a year. Dividends are not included.
Does TORRENT PHARMACEUTICALS L pay a dividend?
Yes. TORRENT PHARMACEUTICALS L's latest dividend went ex on 29 May 2026: Final · ₹9.00 per share. Dividends over the past year come to a yield of 0.80% at the latest close.
What is TORRENT PHARMACEUTICALS L's P/E ratio?
TORRENT PHARMACEUTICALS L's P/E ratio is 80.7: the ₹4,780.00 close on 9 Nov 2026 over trailing twelve-month EPS of ₹59.20 (consolidated, four quarters to 30 Sep 2026).
What is TORRENT PHARMACEUTICALS L's market cap?
TORRENT PHARMACEUTICALS L's market cap is ₹1,81,816 Cr at the close on 9 Nov 2026.
Which sector is TORRENT PHARMACEUTICALS L in?
TORRENT PHARMACEUTICALS L is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how TORRENT PHARMACEUTICALS L fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app